SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-250305
Filing Date
2023-10-04
Accepted
2023-10-04 06:05:00
Documents
15
Period of Report
2023-10-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d547410d8k.htm   iXBRL 8-K 29887
2 EX-99.1 d547410dex991.htm EX-99.1 21763
6 GRAPHIC g547410img001.jpg GRAPHIC 3498
7 GRAPHIC g547410img002.jpg GRAPHIC 3187
  Complete submission text file 0001193125-23-250305.txt   189480

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20231004.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20231004_lab.xml EX-101.LAB 17167
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20231004_pre.xml EX-101.PRE 10784
9 EXTRACTED XBRL INSTANCE DOCUMENT d547410d8k_htm.xml XML 3368
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 231306533
SIC: 2834 Pharmaceutical Preparations